USX:ICLR - ICON PLC (USD 153.41) ICON PLC
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance

USD 153.41    +2.210 (+1.46%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


Overview

9 Apr 2020

Day Change: 2.210 (1.46%)

52 Wk Range: 104.275 - 178.99

Day's Range: 150.31 - 155.0

Last Volume: 307,765

Current Yield: 0%

Projected Yield: 0%

Open: USD 153.64

9 Apr 2020

Metric ICLR S.Median
Beta 0.89 0.84
VaR 18.96 25.23
E.Shortfall 28.42 45.03
Liquidity 269.82K 95.2K

Fundamental


More from Yahoo

General

CEO: Stephen A. Cutler

Headquarters: DUBLIN 18 L2 00000

Employees: 12,500

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. Its clinical development services comprise product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk-based monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services. The company's clinical development services also comprise interactive response technologies, electronic endpoint adjudication, medical imaging, adaptive trial design and execution, medical device and biosimilar trial, functional, strategic resourcing, sample analyses, safety testing, microbiology, custom flow cytometry, biomarker development, bioanalysis, immunoassay development, patient registries, outcomes research, health economics, market access and commercialization, drug price consulting, and healthcare and scientific communication services, as well as research trials for US government agencies, electronic transmission of test results, and electronic patient reported outcomes. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.